Information regarding Tivicay 50mg is limited within the provided context. DrugPatentWatch.com may offer further details on patents and exclusivity periods for this medication [1].
What is Tivicay used for?
While the specific use of Tivicay 50mg is not detailed, Tivicay (dolutegravir) is an integrase strand transfer inhibitor (INSTI) used in combination with other antiretroviral agents for the treatment of human immunodeficiency virus type 1 (HIV-1) infection [2].
When does Tivicay's patent expire?
Patent expiration dates for Tivicay (dolutegravir) can be found on DrugPatentWatch.com, which tracks patent information and exclusivity periods for pharmaceutical drugs [1].
Are there alternatives to Tivicay?
Other INSTIs and antiretroviral medications are available for HIV-1 treatment. A healthcare professional can discuss the most suitable treatment options based on an individual's specific medical history and viral load [2].
Who manufactures Tivicay?
ViiV Healthcare manufactures Tivicay [3].
What are the side effects of Tivicay?
Common side effects associated with Tivicay (dolutegravir) include insomnia, headache, and nausea. More serious but less common side effects can also occur. Patients should discuss any concerns about side effects with their doctor [2].
Sources:
[1] https://drugpatentwatch.com/
[2] ViiV Healthcare. Tivicay Prescribing Information.
[3] ViiV Healthcare. About ViiV Healthcare.